|
C5ORF35 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.664200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.544400E-01 |
| Normal-vs-Stage2 |
3.931400E-01 |
| Normal-vs-Stage3 |
6.092000E-01 |
| Normal-vs-Stage4 |
8.813000E-01 |
| Stage1-vs-Stage2 |
2.009600E-01 |
| Stage1-vs-Stage3 |
6.127600E-01 |
| Stage1-vs-Stage4 |
9.961800E-01 |
| Stage2-vs-Stage3 |
1.464790E-01 |
| Stage2-vs-Stage4 |
3.148200E-01 |
| Stage3-vs-Stage4 |
7.301400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.999000E-01 |
| Normal-vs-AfricanAmerican |
4.104800E-01 |
| Normal-vs-Asian |
2.757900E-02 |
| Caucasian-vs-AfricanAmerican |
1.265830E-01 |
| Caucasian-vs-Asian |
4.369000E-04 |
| AfricanAmerican-vs-Asian |
2.856800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.684400E-01 |
| Normal-vs-Female |
8.743600E-01 |
| Male-vs-Female |
9.689800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.889800E-01 |
| Normal-vs-Age(41-60Yrs) |
6.905600E-01 |
| Normal-vs-Age(61-80Yrs) |
8.334800E-01 |
| Normal-vs-Age(81-100Yrs) |
9.866200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.837200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.945400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.913800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.444200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.682000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.308000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.149640E-01 |
| Classical-VS-Follicular |
1.484160E-02 |
| Classical-VS-Other |
3.820800E-01 |
| Classical-VS-Normal |
5.232200E-01 |
| Tall-VS-Follicular |
6.138400E-03 |
| Tall-VS-Other |
1.435750E-01 |
| Tall-VS-Normal |
9.295800E-02 |
| Follicular-VS-Other |
9.557400E-01 |
| Follicular-VS-Normal |
2.660000E-01 |
| Other-VS-Normal |
5.723200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.177600E-01 |
| Normal-vs-N1 |
6.477600E-01 |
| N0-vs-N1 |
9.382400E-01 |
|
|
